Medical industry looks to tech to cut drug costs

Pharmaceutical firms need better processes and IT systems to make developing new medicines more affordable.

Medical research lab

IT can help reduce the costs involved in drug development and speed it up, too.

Speaking in Geneva at an Intel event at the CERN lab, Karsten Kottig, projects lead at medical tech firm PerkinElmer, explained that pharmaceutical companies are looking to technology to help cut the costs of drug discovery the development that creates new types of medicine.

Processes need improvement, because costs are spiralling every year. "More money into process to get same level of results," he said.

"Pharmaceutical companies have to put a lot of money into the process, but the outcome, the number of really new drugs is very low," he added.

On top of that, drug development can take between seven and 10 years. "We are trying to accelerate that," he said.

With costs in the billions, late stage failures are difficult to make up for. "Each month you work with a failing drug costs a hell a lot of money," he said.

This is where IT comes in. New instruments, data management, and communication methods can all help, and all are supported by software and IT, according to Kottig.

For example, as processors get stronger, better modelling and visualisation can become more detailed and include better content, such as 3D images. This helps drug researchers decide what to focus on sooner rather than later, he explained.

His firm's Opera high throughput microscope offers 3D information. It creates so much data, it includes its own small-cluster computer, featuring three or four rack servers, to analyse 1,000 experiments each day.

"These systems have to deal with a lot of data... and it needs to be stored for 20 years for patent protection," he added.

To help with this, PerkinElmer has worked with Intel to speed up processing power and optimise its products. While Moore's Law has held true and Intel keeps releasing more powerful chipsets, medical applications - like new textural analysis systems - constantly need more and more power. "We are permanently asking for more processing power faster, for our new applications," Kottig said.

Interoperability is key. "If PerkinElmer is no more in 10 years, its current customers still need to be able to access [their data]," he said.

Featured Resources

How virtual desktop infrastructure enables digital transformation

Challenges and benefits of VDI

Free download

The Okta digital trust index

Exploring the human edge of trust

Free download

Optimising workload placement in your hybrid cloud

Deliver increased IT agility with the cloud

Free Download

Modernise endpoint protection and leave your legacy challenges behind

The risk of keeping your legacy endpoint security tools

Download now

Recommended

The IT Pro Podcast: Intel vs AMD
components

The IT Pro Podcast: Intel vs AMD

14 Jan 2022
Intel claims its new Core i9 CPU outperforms Apple's M1 Max
Hardware

Intel claims its new Core i9 CPU outperforms Apple's M1 Max

5 Jan 2022
Delivering on demand: Momentum builds toward flexible IT
Whitepaper

Delivering on demand: Momentum builds toward flexible IT

2 Dec 2021
Intel CPU flaw could enable hackers to attack PCs, cars, and medical devices
Hardware

Intel CPU flaw could enable hackers to attack PCs, cars, and medical devices

16 Nov 2021

Most Popular

How to move Microsoft's Windows 11 from a hard drive to an SSD
Microsoft Windows

How to move Microsoft's Windows 11 from a hard drive to an SSD

4 Jan 2022
Microsoft Exchange servers break thanks to 'Y2K22' bug
email delivery

Microsoft Exchange servers break thanks to 'Y2K22' bug

4 Jan 2022
Solving cyber security's diversity problem
Careers & training

Solving cyber security's diversity problem

5 Jan 2022